Reply to “Do not de‐escalate oncology care in oropharyngeal cancer routinely”
- 12 September 2019
- journal article
- letter
- Published by Wiley in Head & Neck
- Vol. 42 (1) , 145-146
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2019
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)Journal for ImmunoTherapy of Cancer, 2019
- Patients' preferences concerning follow‐up after curative head and neck cancer treatment: A cross‐sectional pilot studyHead & Neck, 2019
- Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV− oropharyngeal squamous cell carcinoma: A population-based studyOral Oncology, 2018
- Determining optimal follow‐up in the management of human papillomavirus‐positive oropharyngeal cancerCancer, 2015
- Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With ChemoradiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2015
- Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell CarcinomaJournal of Clinical Oncology, 2014
- Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancerOral Oncology, 2013
- Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionationRadiotherapy and Oncology, 2012
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010